Skip to content

DR. ZIANI

Active
Private limited company·Activiteiten van huisartspraktijken· 5 yrs active
Schoonslaapsterstraat 16 ·1080 Sint-Jans-Molenbeek, Belgium
KBO/BCE: BE 0766.712.546
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of DR. ZIANI is 0.3% (very low). The 2024 annual accounts show equity of €430k and a net result of €162k. Equity is growing by ~20.5% per year across the filed fiscal years. Its solvency ranks better than 33% of 6558 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€162k+87.9%
Working capital€256k-36.5%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 22-07-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200kOperating result 2021: €245k€245kNet result 2021: €188k€188kOperating result 2022: €249k€249kNet result 2022: €190k€190kOperating result 2023: €120k€120kNet result 2023: €86k€86kOperating result 2024: €222k€222kNet result 2024: €162k€162k2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~20.5%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k€800k€1.00M2025: €577k (€477k - €676k)2026: €660k (€500k - €819k)2027: €743k (€523k - €962k)2021: €191k2022: €381k2023: €468k2024: €430k2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 47.5% 66.7%
better than 33% of 6558 sector peers
Net result €162k €46k
better than 90% of 6552 sector peers
Equity €430k €79k
better than 94% of 6558 sector peers
Gross operating margin €245k €78k
better than 90% of 6560 sector peers
Total assets €906k €154k
better than 95% of 6561 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P33
2021: P95 · n=18222022: P95 · n=36542023: P35 · n=53162024: P33 · n=65582021 2024
Weakening position over 2021-2024 · n=1822-6558
Net result P90
2021: P94 · n=18222022: P95 · n=36522023: P78 · n=53152024: P90 · n=65522021 2024
Stable position over 2021-2024 · n=1822-6552
Equity P94
2021: P82 · n=18222022: P94 · n=36542023: P95 · n=53182024: P94 · n=65582021 2024
Stable position over 2021-2024 · n=1822-6558
Gross operating margin P90
2021: P91 · n=18232022: P93 · n=36502023: P90 · n=53122024: P90 · n=65602021 2024
Stable position over 2021-2024 · n=1823-6560
Describes the position versus peers, not a forecast.
EBITDA
€241k
+16.1% +232% vs sector
Net profit
€162k
+87.9% +232% vs sector
Cash flow
€181k
+4.6% +203% vs sector
Total assets
€906k
-5.4% +169% vs sector
Equity
€430k
-8.1% +60% vs sector
Working capital
€256k
-36.5% +1% vs sector
Income taxes
€45k
+100.8% far above sector median
Dividends
€200k
- +62% vs sector
Debt
€476k
-2.9% far above sector median
Debt ≤ 1y
€22k
+19.1% -33% vs sector
Debt > 1y
€454k
-3.8% 21-24
Current ratio
12.66
-44.6% +100% vs sector
Quick ratio
12.66
-44.6% +100% vs sector
Solvency
47.5%
-2.8% -47% vs sector
Debt / equity
1.11
+5.6% far above sector median
ROE
37.7%
+104.4% +150% vs sector
ROA
17.9%
+98.7% +25% vs sector
Interest coverage
11.46
-11.1% -83% vs sector
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€241k
Net profit€162k
Cash flow€181k
Staff costs-
Income taxes€45k
Dividends€200k
Total assets€906k
Equity€430k
Debt€476k
of which ≤ 1y€22k
of which > 1y€454k
Working capital€256k
Employees (FTE)-
Ratios (computed)
2024
Current ratio12.66
Quick ratio12.66
Working capital ratio28.2%
Solvency47.5%
Debt / equity1.11
Long-term debt ratio1.06
Interest coverage11.46
Gross margin-
Net margin-
ROA17.9%
ROE37.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€906k
Fixed assets 21/28€628k
Tangible fixed assets 22/27€628k
Current assets 29/58€278k
Amounts receivable within one year 40/41€32k
Cash & bank 54/58€222k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€906k
Equity 10/15€430k
Contributions / capital 10/11€3k
Reserves 13€427k
Amounts payable 17/49€476k
Amounts payable after one year 17€454k
Amounts payable within one year 42/48€22k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€245k
Operating result 9901€222k
Financial income 75€7k
Financial charges 65€21k
Result before taxes 9903€207k
Income taxes 67/77€45k
Net result for the period 9904€162k
Result to be appropriated 9905€162k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
91 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
Clinique de la Sagesse
Graaf van Vlaanderenstraat 46, 1080 Sint-Jans-MolenbeekActiviteiten van huisartspraktijken
since 20212.316.067.119
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area612 m²
Buildings2
Building footprint393 m²
Volume (LiDAR)3,684 m³
Tallest building23.3 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21524C0063/00N004 Brussels 325 m² 1 · 159 m² 18.6 m · 5 fl.
21522B0223/00H000 Brussels 287 m² 1 · 235 m² 23.3 m · 1 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health91Profitability100Solvency93Growth52Stability94
86 / 100

Exceptional profile, strong across almost every axis.

Health 91
Profitability 100
Solvency 93
Growth 52
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten van huisartspraktijken86210
Primary activity highlighted.
Names & trade names
Legal nameFR DR. ZIANI
Registered office
Schoonslaapsterstraat 16 bus 4
1080 Sint-Jans-Molenbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.